SCHEMBL7697363

SCHEMBL7697363

O=C(NCc1ccc(Cl)cc1)C1CCC(Nc2nc3ccccc3[nH]2)CC1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.55
KDM4E B2RXH2 1/20 0.53
LMNA P02545 2/20 0.52
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
POLB P06746 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
MAPT P10636 1/20 0.47
TP53 P04637 1/20 0.47
ALDH1A1 P00352 2/20 0.46
BACE1 P56817 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7695718 1.00 SMN1; SMN2 (0.55) SMN1; SMN2KDM4ELMNANPC1RAB9A
SCHEMBL7085654 0.92 SMN1; SMN2 (0.59) SMN1; SMN2KDM4ENPC1RAB9APOLB
SCHEMBL7085647 0.92 SMN1; SMN2 (0.59) SMN1; SMN2KDM4ENPC1RAB9APOLB
SCHEMBL7089468 0.92 SMN1; SMN2 (0.59) SMN1; SMN2KDM4ENPC1RAB9APOLB
SCHEMBL7692451 0.90 SMN1; SMN2 (0.55) SMN1; SMN2LMNANPC1RAB9APOLB
SCHEMBL7698837 0.90 SMN1; SMN2 (0.55) SMN1; SMN2LMNANPC1RAB9APOLB
SCHEMBL7693632 0.90 SMN1; SMN2 (0.55) SMN1; SMN2KDM4ELMNANPC1RAB9A
SCHEMBL7693636 0.90 SMN1; SMN2 (0.55) SMN1; SMN2KDM4ELMNANPC1RAB9A
SCHEMBL7695789 0.89 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9APOLBTDP1
SCHEMBL7695794 0.89 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9APOLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US claimed
US-6380205-B1 QUINAZOLINE THROUGH A C1-C4ALKYL, C1- C4ALKENYL, C1-C4ALKYNYL, C1-C4ALKOXY, AMINO, AMINOC1-C4ALKYL, HYDROXYC1-C4ALKYL, CARBONYL, CYCLOC3-C6ALKYL OR AMINOCARBONYL CHAIN, USEFUL FOR TREATMENT OF THE PAIN MERCK & CO., INC. 2002-04-30 US disclosed
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US disclosed